Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Serono Expand Proteomics Deal

NEW YORK, Jan. 28-Inpharmatica and Serono are expanding their proteomics  collaboration, the two companies said this morning.

 

The two firms struck a collaboration in mid-2001 in which Inpharmatica supplies Serono with protein sequences to aid in drug and drug target discovery.

 

This agreement expands the deal, so that Inpharmatica will provide additional proprietary genomic sequence data from other protein families.

 

Inpharmatica will receive milestone and royalty payments based on any products developed, as well as additional research funding.

 

Inpharmatica, based in London, uses informatics and a large compute farm to analyze protein data for drug discovery.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.